{"title":"骨转移的医学预防与治疗","authors":"C. Handforth, S. D’Oronzo, Janet E Brown","doi":"10.1002/9781119266594.CH104","DOIUrl":null,"url":null,"abstract":"The presence of metastatic bone disease is a devastating \ncomplication that has signiicant impact on morbidity \nand mortality in cancer patients. Although the type, incidence, \nand consequences of bone metastases (BM) may \nvary between primary cancer sites, all patients with BM \nrequire consideration as to how both their primary \ntumour and their bone disease should be managed in \nterms of avoiding complications and maximizing both \nquality of life and survival. This chapter will describe \nnormal bone turnover, the pathophysiology of BM, and \nthe most common clinical sequelae. We will then explain \nthe current evidence for the prevention and treatment of \nBM for the most osteotropic tumours (breast, prostate, \nlung, and renal).","PeriodicalId":303630,"journal":{"name":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Medical Prevention and Treatment of Bone Metastases\",\"authors\":\"C. Handforth, S. D’Oronzo, Janet E Brown\",\"doi\":\"10.1002/9781119266594.CH104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The presence of metastatic bone disease is a devastating \\ncomplication that has signiicant impact on morbidity \\nand mortality in cancer patients. Although the type, incidence, \\nand consequences of bone metastases (BM) may \\nvary between primary cancer sites, all patients with BM \\nrequire consideration as to how both their primary \\ntumour and their bone disease should be managed in \\nterms of avoiding complications and maximizing both \\nquality of life and survival. This chapter will describe \\nnormal bone turnover, the pathophysiology of BM, and \\nthe most common clinical sequelae. We will then explain \\nthe current evidence for the prevention and treatment of \\nBM for the most osteotropic tumours (breast, prostate, \\nlung, and renal).\",\"PeriodicalId\":303630,\"journal\":{\"name\":\"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism\",\"volume\":\"28 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/9781119266594.CH104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9781119266594.CH104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Medical Prevention and Treatment of Bone Metastases
The presence of metastatic bone disease is a devastating
complication that has signiicant impact on morbidity
and mortality in cancer patients. Although the type, incidence,
and consequences of bone metastases (BM) may
vary between primary cancer sites, all patients with BM
require consideration as to how both their primary
tumour and their bone disease should be managed in
terms of avoiding complications and maximizing both
quality of life and survival. This chapter will describe
normal bone turnover, the pathophysiology of BM, and
the most common clinical sequelae. We will then explain
the current evidence for the prevention and treatment of
BM for the most osteotropic tumours (breast, prostate,
lung, and renal).